List of Tables
Table 1. Global Newcastle Disease Vaccine Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Newcastle Disease Vaccine Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Newcastle Disease Vaccine Market Competitive Situation by Manufacturers in 2025
Table 4. Global Newcastle Disease Vaccine Sales (M Doses) of Key Manufacturers (2021–2026)
Table 5. Global Newcastle Disease Vaccine Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Newcastle Disease Vaccine Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Newcastle Disease Vaccine Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Newcastle Disease Vaccine Average Price (USD/K Doses) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Newcastle Disease Vaccine, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Newcastle Disease Vaccine, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Newcastle Disease Vaccine, Product Types and Applications
Table 12. Global Key Manufacturers of Newcastle Disease Vaccine, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Newcastle Disease Vaccine Companies by Tier (Tier 1, Tier 2, Tier 3), based on Newcastle Disease Vaccine Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Newcastle Disease Vaccine Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Newcastle Disease Vaccine Sales by Region (M Doses), 2021–2026
Table 18. Global Newcastle Disease Vaccine Sales Market Share by Region (2021–2026)
Table 19. Global Newcastle Disease Vaccine Sales by Region (M Doses), 2027–2032
Table 20. Global Newcastle Disease Vaccine Sales Market Share by Region (2027–2032)
Table 21. Global Newcastle Disease Vaccine Revenue by Region (US$ Million), 2021–2026
Table 22. Global Newcastle Disease Vaccine Revenue Market Share by Region (2021–2026)
Table 23. Global Newcastle Disease Vaccine Revenue by Region (US$ Million), 2027–2032
Table 24. Global Newcastle Disease Vaccine Revenue Market Share by Region (2027–2032)
Table 25. North America Newcastle Disease Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Newcastle Disease Vaccine Sales by Country (M Doses), 2021–2026
Table 27. North America Newcastle Disease Vaccine Sales by Country (M Doses), 2027–2032
Table 28. North America Newcastle Disease Vaccine Revenue by Country (US$ Million), 2021–2026
Table 29. North America Newcastle Disease Vaccine Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Newcastle Disease Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Newcastle Disease Vaccine Sales by Country (M Doses), 2021–2026
Table 32. Europe Newcastle Disease Vaccine Sales by Country (M Doses), 2027–2032
Table 33. Europe Newcastle Disease Vaccine Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Newcastle Disease Vaccine Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Newcastle Disease Vaccine Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Newcastle Disease Vaccine Sales by Region (M Doses), 2021–2026
Table 37. Asia Pacific Newcastle Disease Vaccine Sales by Region (M Doses), 2027–2032
Table 38. Asia Pacific Newcastle Disease Vaccine Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Newcastle Disease Vaccine Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Newcastle Disease Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Newcastle Disease Vaccine Sales by Country (M Doses), 2021–2026
Table 42. Latin America Newcastle Disease Vaccine Sales by Country (M Doses), 2027–2032
Table 43. Latin America Newcastle Disease Vaccine Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Newcastle Disease Vaccine Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Newcastle Disease Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Newcastle Disease Vaccine Sales by Country (M Doses), 2021–2026
Table 47. Middle East and Africa Newcastle Disease Vaccine Sales by Country (M Doses), 2027–2032
Table 48. Middle East and Africa Newcastle Disease Vaccine Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Newcastle Disease Vaccine Revenue by Country (US$ Million), 2027–2032
Table 50. Global Newcastle Disease Vaccine Sales (M Doses) by Type (2021–2026)
Table 51. Global Newcastle Disease Vaccine Sales (M Doses) by Type (2027–2032)
Table 52. Global Newcastle Disease Vaccine Sales Market Share by Type (2021–2026)
Table 53. Global Newcastle Disease Vaccine Sales Market Share by Type (2027–2032)
Table 54. Global Newcastle Disease Vaccine Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Newcastle Disease Vaccine Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Newcastle Disease Vaccine Revenue Market Share by Type (2021–2026)
Table 57. Global Newcastle Disease Vaccine Revenue Market Share by Type (2027–2032)
Table 58. Global Newcastle Disease Vaccine Price (USD/K Doses) by Type (2021–2026)
Table 59. Global Newcastle Disease Vaccine Price (USD/K Doses) by Type (2027–2032)
Table 60. Global Newcastle Disease Vaccine Sales (M Doses) by Application (2021–2026)
Table 61. Global Newcastle Disease Vaccine Sales (M Doses) by Application (2027–2032)
Table 62. Global Newcastle Disease Vaccine Sales Market Share by Application (2021–2026)
Table 63. Global Newcastle Disease Vaccine Sales Market Share by Application (2027–2032)
Table 64. Global Newcastle Disease Vaccine Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Newcastle Disease Vaccine Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Newcastle Disease Vaccine Revenue Market Share by Application (2021–2026)
Table 67. Global Newcastle Disease Vaccine Revenue Market Share by Application (2027–2032)
Table 68. Global Newcastle Disease Vaccine Price (USD/K Doses) by Application (2021–2026)
Table 69. Global Newcastle Disease Vaccine Price (USD/K Doses) by Application (2027–2032)
Table 70. Merial Company Information
Table 71. Merial Description and Business Overview
Table 72. Merial Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses), and Gross Margin (2021–2026)
Table 73. Merial Newcastle Disease Vaccine Product
Table 74. Merial Recent Developments/Updates
Table 75. CEVA Company Information
Table 76. CEVA Description and Business Overview
Table 77. CEVA Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses), and Gross Margin (2021–2026)
Table 78. CEVA Newcastle Disease Vaccine Product
Table 79. CEVA Recent Developments/Updates
Table 80. QYH Biotech Company Information
Table 81. QYH Biotech Description and Business Overview
Table 82. QYH Biotech Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses), and Gross Margin (2021–2026)
Table 83. QYH Biotech Newcastle Disease Vaccine Product
Table 84. QYH Biotech Recent Developments/Updates
Table 85. Ringpu Biology Company Information
Table 86. Ringpu Biology Description and Business Overview
Table 87. Ringpu Biology Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses), and Gross Margin (2021–2026)
Table 88. Ringpu Biology Newcastle Disease Vaccine Product
Table 89. Ringpu Biology Recent Developments/Updates
Table 90. Yebio Company Information
Table 91. Yebio Description and Business Overview
Table 92. Yebio Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses), and Gross Margin (2021–2026)
Table 93. Yebio Newcastle Disease Vaccine Product
Table 94. Yebio Recent Developments/Updates
Table 95. Harbin Veterinary Research Institute Company Information
Table 96. Harbin Veterinary Research Institute Description and Business Overview
Table 97. Harbin Veterinary Research Institute Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses), and Gross Margin (2021–2026)
Table 98. Harbin Veterinary Research Institute Newcastle Disease Vaccine Product
Table 99. Harbin Veterinary Research Institute Recent Developments/Updates
Table 100. Merck Animal Health Company Information
Table 101. Merck Animal Health Description and Business Overview
Table 102. Merck Animal Health Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses), and Gross Margin (2021–2026)
Table 103. Merck Animal Health Newcastle Disease Vaccine Product
Table 104. Merck Animal Health Recent Developments/Updates
Table 105. DHN Company Information
Table 106. DHN Description and Business Overview
Table 107. DHN Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses), and Gross Margin (2021–2026)
Table 108. DHN Newcastle Disease Vaccine Product
Table 109. DHN Recent Developments/Updates
Table 110. Zoetis Company Information
Table 111. Zoetis Description and Business Overview
Table 112. Zoetis Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses), and Gross Margin (2021–2026)
Table 113. Zoetis Newcastle Disease Vaccine Product
Table 114. Zoetis Recent Developments/Updates
Table 115. ChengDu Tecbond Company Information
Table 116. ChengDu Tecbond Description and Business Overview
Table 117. ChengDu Tecbond Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses), and Gross Margin (2021–2026)
Table 118. ChengDu Tecbond Newcastle Disease Vaccine Product
Table 119. ChengDu Tecbond Recent Developments/Updates
Table 120. Elanco (Lohmann) Company Information
Table 121. Elanco (Lohmann) Description and Business Overview
Table 122. Elanco (Lohmann) Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses), and Gross Margin (2021–2026)
Table 123. Elanco (Lohmann) Newcastle Disease Vaccine Product
Table 124. Elanco (Lohmann) Recent Developments/Updates
Table 125. FATRO Company Information
Table 126. FATRO Description and Business Overview
Table 127. FATRO Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses), and Gross Margin (2021–2026)
Table 128. FATRO Newcastle Disease Vaccine Product
Table 129. FATRO Recent Developments/Updates
Table 130. CAVAC Company Information
Table 131. CAVAC Description and Business Overview
Table 132. CAVAC Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses), and Gross Margin (2021–2026)
Table 133. CAVAC Newcastle Disease Vaccine Product
Table 134. CAVAC Recent Developments/Updates
Table 135. Vaksindo Company Information
Table 136. Vaksindo Description and Business Overview
Table 137. Vaksindo Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses), and Gross Margin (2021–2026)
Table 138. Vaksindo Newcastle Disease Vaccine Product
Table 139. Vaksindo Recent Developments/Updates
Table 140. Key Raw Materials Lists
Table 141. Raw Materials Key Suppliers Lists
Table 142. Newcastle Disease Vaccine Distributors List
Table 143. Newcastle Disease Vaccine Customers List
Table 144. Newcastle Disease Vaccine Market Trends
Table 145. Newcastle Disease Vaccine Market Drivers
Table 146. Newcastle Disease Vaccine Market Challenges
Table 147. Newcastle Disease Vaccine Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
Table 151. Authors List of This Report
List of Figures
Figure 1. Product Picture of Newcastle Disease Vaccine
Figure 2. Global Newcastle Disease Vaccine Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Newcastle Disease Vaccine Market Share by Type: 2025 & 2032
Figure 4. Live Vaccines Product Picture
Figure 5. Killed Vaccines Product Picture
Figure 6. Global Newcastle Disease Vaccine Market Value by Application (US$ Million), 2021–2032
Figure 7. Global Newcastle Disease Vaccine Market Share by Application: 2025 & 2032
Figure 8. Chicken
Figure 9. Duck & Goose
Figure 10. Other
Figure 11. Global Newcastle Disease Vaccine Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 12. Global Newcastle Disease Vaccine Market Size (US$ Million), 2021–2032
Figure 13. Global Newcastle Disease Vaccine Sales (M Doses), 2021–2032
Figure 14. Global Newcastle Disease Vaccine Average Price (USD/K Doses), 2021–2032
Figure 15. Newcastle Disease Vaccine Report Years Considered
Figure 16. Newcastle Disease Vaccine Sales Share by Manufacturers in 2025
Figure 17. Global Newcastle Disease Vaccine Revenue Share by Manufacturers in 2025
Figure 18. Top 5 and Top 10 Global Newcastle Disease Vaccine Players: Market Share by Revenue in Newcastle Disease Vaccine in 2025
Figure 19. Newcastle Disease Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 20. Global Newcastle Disease Vaccine Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 21. North America Newcastle Disease Vaccine Sales Market Share by Country (2021–2032)
Figure 22. North America Newcastle Disease Vaccine Revenue Market Share by Country (2021–2032)
Figure 23. U.S. Newcastle Disease Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 24. Canada Newcastle Disease Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Europe Newcastle Disease Vaccine Sales Market Share by Country (2021–2032)
Figure 26. Europe Newcastle Disease Vaccine Revenue Market Share by Country (2021–2032)
Figure 27. Germany Newcastle Disease Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. France Newcastle Disease Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. U.K. Newcastle Disease Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. Italy Newcastle Disease Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Russia Newcastle Disease Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Asia Pacific Newcastle Disease Vaccine Sales Market Share by Region (2021–2032)
Figure 33. Asia Pacific Newcastle Disease Vaccine Revenue Market Share by Region (2021–2032)
Figure 34. China Newcastle Disease Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Japan Newcastle Disease Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. South Korea Newcastle Disease Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. India Newcastle Disease Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Australia Newcastle Disease Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. China Taiwan Newcastle Disease Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Indonesia Newcastle Disease Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Thailand Newcastle Disease Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Malaysia Newcastle Disease Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Philippines Newcastle Disease Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Latin America Newcastle Disease Vaccine Sales Market Share by Country (2021–2032)
Figure 45. Latin America Newcastle Disease Vaccine Revenue Market Share by Country (2021–2032)
Figure 46. Mexico Newcastle Disease Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Brazil Newcastle Disease Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Argentina Newcastle Disease Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Middle East and Africa Newcastle Disease Vaccine Sales Market Share by Country (2021–2032)
Figure 50. Middle East and Africa Newcastle Disease Vaccine Revenue Market Share by Country (2021–2032)
Figure 51. Turkey Newcastle Disease Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Saudi Arabia Newcastle Disease Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. U.A.E Newcastle Disease Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. Global Sales Market Share of Newcastle Disease Vaccine by Type (2021–2032)
Figure 55. Global Revenue Market Share of Newcastle Disease Vaccine by Type (2021–2032)
Figure 56. Global Newcastle Disease Vaccine Price (USD/K Doses) by Type (2021–2032)
Figure 57. Global Sales Market Share of Newcastle Disease Vaccine by Application (2021–2032)
Figure 58. Global Revenue Market Share of Newcastle Disease Vaccine by Application (2021–2032)
Figure 59. Global Newcastle Disease Vaccine Price (USD/K Doses) by Application (2021–2032)
Figure 60. Newcastle Disease Vaccine Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
